ViewTube

Explore our coverage of hematological malignancies, including CLL, lymphoma, multiple myeloma, AML, MDS, MPNs, CML, ALL.

Amer Zeidan, MBBS, MHS, Yale University and Yale Cancer Center, New Haven, CT, discusses the upcoming post-ASH webinar ...

Alan List, MD, Tampa, FL, provides VJHemOnc with an overview of myelodysplastic syndromes (MDS), and how we can treat ...

Surbhi Sidana, MD, Stanford University, Stanford, CA, discusses the two-year follow-up results of MajesTEC-1 trial ...

Visit VJHemOnc.com to explore the latest updates in the field of multiple myeloma, including updates from COMy, EHA and ASH!

Visit VJHemOnc.com to explore the latest updates in the field of multiple myeloma, including updates from COMy, EHA and ASH!

Heidi Elmoazzen, PhD, Canadian Blood Services, Ottawa, Canada, discusses the impact of COVID-19 on cord blood banking.

Akshay Sharma, MBBS, St. Jude Children's Research Hospital, Memphis, TN, discusses the results of a study evaluating the ...

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, comments on the measurable residual disease (MRD) negativity rates observed in ...

Shebli Atrash, MD, Levine Cancer Institute & Atrium Health, Charlotte, NC, discusses mechanisms of resistance to CAR T-cells in ...

Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, ...

The European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA) organised ...

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses recent updates on the use of CAR-T therapy in ...

Loretta Nastoupil, MD, University of Texas MD Anderson Center, Houston, TX, discusses the value of women as healthcare ...

Krina Patel, MD, MSc, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the growing body of evidence ...

Julio Chavez, MD, MS, Moffitt Cancer Center, Tampa, FL, presents the results from a multicenter study looking at patients 80 and ...

Kenneth Anderson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the next steps towards a cure in the myeloma field.

Caspian Oliai, MD, MS, University of California, Los Angeles, Los Angeles, CA, discusses the rationale and results of a Phase Ib ...